EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN PATIENTS WITH DECOMPENSATED HEPATITIS B CIRRHOSIS

被引：0
|
作者：
Deng, You [1 ]
Cui, Weili [2 ]
Yue, Jin [3 ]
Li, Jinlong [4 ]
Zhang, Shuqian [1 ]
Wang, Qi [1 ]
Zhao, Hong [1 ]
Chen, Wenya [1 ]
Li, Jiashuo [1 ]
Li, Mengqi [1 ]
Lai, Xiaohuan [4 ]
Guo, Xiaoqing [3 ]
Qiao, Bing [2 ]
Xie, Wen [1 ]
机构：
[1] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China
[2] Qingdao Sixth Peoples Hosp, Qingdao, Peoples R China
[3] Third Peoples Hosp Taiyuan, Taiyuan, Peoples R China
[4] Ganzhou Fifth Peoples Hosp, Ganzhou, Peoples R China
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2241
引用
收藏
页码：S1696 / S1697
页数：2
相关论文
共 50 条
  • [41] Clinical Efficacy and Safety of Tenofovir in the Treatment of Patients with Chronic Hepatitis B
    He, Feng
    Xia, Zhongjiang
    Wang, Hui
    Zhu, Jinjun
    Hu, Laiwen
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [42] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF)
    Schwarz, Kathleen B.
    Bezerra, Jorge
    Choe, Byung-ho
    Lin, Chuan-Hao
    Abramov, Frida
    Wang, Hongyuan
    Liu, Yang
    Flaherty, John F.
    Pacurar, Daniela
    Kim, Kyung Mo
    Khaertynova, Ilsiyar
    Shalimar
    Wu, Jia-Feng
    Tandon, Manish
    Rosenthal, Philip
    Morozov, Viacheslav
    Sokal, Etinne
    Chang, Mei-Hwei
    GASTROENTEROLOGY, 2023, 164 (06) : S1237 - S1238
  • [43] REAL WORLD COMPARISON OF RENAL SAFETY IN PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE VS TENOFOVIR ALAFENAMIDE FOR CHRONIC HEPATITIS B
    Zhang, Xueyun
    Hu, Qiankun
    Liu, Xiaoqin
    Huang, Yuxian
    HEPATOLOGY, 2021, 74 : 490A - 491A
  • [44] Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
    Lin, Hung-Yao
    Tseng, Tai-Chung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2022, 28 (02) : 181 - 182
  • [45] Tenofovir Alafenamide Rescues Renal Tubules in Patients with Chronic Hepatitis B
    Sano, Tomoya
    Kawaguchi, Takumi
    Ide, Tatsuya
    Amano, Keisuke
    Kuwahara, Reiichiro
    Arinaga-Hino, Teruko
    Torimura, Takuji
    LIFE-BASEL, 2021, 11 (03):
  • [46] Safety and Efficacy of Simeprevir and Sofosbuvir in Patients with Decompensated Cirrhosis
    Lingala, Shilpa
    Satapathy, Sanjaya K.
    Dbouk, Nader
    Nair, Satheesh
    HEPATOLOGY, 2014, 60 : 688A - 688A
  • [47] Safety and efficacy at 1 year after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide in patients with chronic hepatitis B and risk factors for TDF use
    Gane, E.
    Seto, W. K.
    Janssen, H.
    Caruntu, F. A.
    Kim, H. J.
    Abdurakhmanov, D.
    Nishiguchi, S.
    Andrzej, H.
    Bae, H.
    Mo, S.
    Suri, V.
    Gaggar, A.
    Flaherty, J. F.
    Kao, J-H
    Brunetto, M.
    Buti Ferret, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 42 - 43
  • [48] A PHASE 3 STUDY OF TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE IN PATIENTS WITH HBEAG-NEGATIVE, CHRONIC HEPATITIS B: WEEK 48 EFFICACY AND SAFETY RESULTS
    Buti, M.
    Gane, E.
    Seto, W. K.
    Chan, H. L. Y.
    Chuang, W. -L.
    Stepanova, T.
    Hui, A. J.
    Lim, Y. -S.
    Mehta, R.
    Janssen, H. L. A.
    Acharya, S. K.
    Flaherty, J. F.
    Massetto, B.
    Cathcart, A.
    Dinh, P.
    Subramanian, G. M.
    McHutchison, J. G.
    Pan, C.
    Brunetto, M.
    Izumi, N.
    Marcellin, P.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S135 - S136
  • [49] A phase 3 study comparing tenofovir alafenamide to tenofovir disoproxil fumarate in patients with HBeAg-negative, chronic hepatitis B: efficacy and safety results at week 96
    Brunetto, M.
    Lim, Y. S.
    Gane, E.
    Seto, W. K.
    Osipenko, M.
    Ahn, S. H.
    Janssen, H. L.
    Shukla, A.
    Chuang, W. L.
    Trinh, H.
    Celen, M. K.
    Flaherty, J. F.
    Lau, A. H.
    Gaggar, A.
    Suri, V.
    Bhardwaj, N.
    Kim, K.
    Subramanian, G. M.
    Pan, C.
    Izumi, N.
    Marcellin, P.
    Chan, H.
    Buti, M.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S25 - S26
  • [50] Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
    Hong, Hyeyeon
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (01) : 49 - 63
12345